Is VYNE Therapeutics financially healthy?
Yes
VYNE Therapeutics holds more cash than debt.
The numbers behind it
Net debt / EBITDANet cash
Cash vs. debt$24M vs. $0
Current ratio12.5×Short-term assets for each $1 of bills due within a year
How we decide
We measure debt in years of earnings (net debt / EBITDA): under 1 is very comfortable, 1 to 3 is manageable, above 3 is heavy. A company that earns less than 3 times its interest bill also counts as weak.
More questions about VYNE Therapeutics
Data as of Jul 27, 2026.